We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Chancery Nixes Injunction in Feud Over Akrimax Drug Rights

Law360, Wilmington (February 8, 2016, 8:56 PM EST) -- An Akrimax Pharmaceuticals LLC investor lost a bid Monday for a preliminary injunction freezing the status of the company and a drug license allegedly in play for $250 million or more,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.